Corporate

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Corporate
magAssist Included in 2022 China Valuable Companies List 2023-01-31
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16
Corporate
magAssist Wins Final of 11th China Innovation & Entrepreneurship Competition 2023-01-13
Corporate
magAssist Forges University-Enterprise Cooperation with Domestic and International Universities to Empower Innovative Talents Cultivation Scheme 2023-01-12
Corporate
magAssist Included in List of 2022 Potential Unicorn Companies in Jiangsu Province 2022-12-15
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees 2022-12-14
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China 2022-11-03
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022. 2022-09-30

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,